Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Thabit, Abrar K.
Alam, M. Jahangir
Khaleduzzaman, Mohammed
Garey, Kevin W.
and
Nicolau, David P.
2016.
A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin.
Annals of Clinical Microbiology and Antimicrobials,
Vol. 15,
Issue. 1,
Thabit, Abrar K.
Alam, M. Jahangir
Burnham, Carey-Ann D.
and
Nicolau, David P.
2017.
Clinical use comparison of a semiautomated PCR with fluorescent ribotyping for typing of Clostridium difficile.
Archives of Microbiology,
Vol. 199,
Issue. 2,
p.
317.
Burton, Hannah E.
Mitchell, Stephen A.
and
Watt, Maureen
2017.
A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection.
PharmacoEconomics,
Vol. 35,
Issue. 11,
p.
1123.
Diorio, Caroline
Robinson, Paula D.
Ammann, Roland A.
Castagnola, Elio
Erickson, Kelley
Esbenshade, Adam
Fisher, Brian T.
Haeusler, Gabrielle M.
Kuczynski, Susan
Lehrnbecher, Thomas
Phillips, Robert
Cabral, Sandra
Dupuis, L. Lee
and
Sung, Lillian
2018.
Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients.
Journal of Clinical Oncology,
Vol. 36,
Issue. 31,
p.
3162.
Thabit, Abrar K.
Alsolami, Mawadah H.
Baghlaf, Nojoud A.
Alsharekh, Raghad M.
Almazmumi, Hadeel A.
Alselami, Afrah S.
and
Alsubhi, Fatmah A.
2019.
Comparison of three current Clostridioides difficile infection guidelines: IDSA/SHEA, ESCMID, and ACG guidelines.
Infection,
Vol. 47,
Issue. 6,
p.
899.
Aljafel, Nouf A.
Al-Shaikhy, Hadeel H.
Alnahdi, Maram A.
and
Thabit, Abrar K.
2020.
Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period.
Journal of Infection and Public Health,
Vol. 13,
Issue. 8,
p.
1156.
Wu, Kuan-Sheng
Syue, Ling-Shan
Cheng, Aristine
Yen, Ting-Yu
Chen, Hsien-Meng
Chiu, Yu-Hsin
Hsu, Yu-Lung
Chiu, Chun-Hsiang
Su, Ting-Yi
Tsai, Wan-Lin
Chen, Wei-Yu
Huang, Chung-Hao
Hung, Huei-Min
Huang, Ling-Ju
Kuo, Hong-Jie
Lin, Pei-Chin
Yang, Ching-Hsiang
Hong, Pi-Lien
Lee, Susan Shin-Jung
Chen, Yao-Shen
Liu, Yung-Ching
and
Huang, Li-Ming
2020.
Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan.
Journal of Microbiology, Immunology and Infection,
Vol. 53,
Issue. 2,
p.
191.
Bermejo Boixareu, Cristina
Tutor-Ureta, Pablo
and
Ramos Martínez, Antonio
2020.
Actualización sobre infección por Clostridium difficile en el paciente mayor.
Revista Española de Geriatría y Gerontología,
Vol. 55,
Issue. 4,
p.
225.
van Prehn, Joffrey
Reigadas, Elena
Vogelzang, Erik H.
Bouza, Emilio
Hristea, Adriana
Guery, Benoit
Krutova, Marcela
Norén, Torbjorn
Allerberger, Franz
Coia, John E.
Goorhuis, Abraham
van Rossen, Tessel M.
Ooijevaar, Rogier E.
Burns, Karen
Scharvik Olesen, Bente R.
Tschudin-Sutter, Sarah
Wilcox, Mark H.
Vehreschild, Maria J.G.T.
Fitzpatrick, Fidelma
and
Kuijper, Ed J.
2021.
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
Clinical Microbiology and Infection,
Vol. 27,
Issue. ,
p.
S1.
Rinaldi, Alyssa
Reed, Erica E.
Stevenson, Kurt B.
Coe, Kelci
and
Smith, Jessica M.
2021.
Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent
clostridioides difficile
.
Journal of Clinical Pharmacy and Therapeutics,
Vol. 46,
Issue. 4,
p.
993.
Tixier, Emily N.
Verheyen, Elijah
Luo, Yuying
Grinspan, Lauren Tal
Du, Charles H.
Ungaro, Ryan C.
Walsh, Samantha
and
Grinspan, Ari M.
2022.
Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
Digestive Diseases and Sciences,
Vol. 67,
Issue. 3,
p.
978.
Turner, Nicholas A
Warren, Bobby G
Gergen-Teague, Maria F
Addison, Rachel M
Addison, Bechtler
Rutala, William A
Weber, David J
Sexton, Daniel J
and
Anderson, Deverick J
2022.
Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile
.
Clinical Infectious Diseases,
Vol. 74,
Issue. 4,
p.
648.
Tashiro, Sho
Mihara, Takayuki
Sasaki, Moe
Shimamura, Chiaki
Shimamura, Rina
Suzuki, Shiho
Yoshikawa, Maiko
Hasegawa, Tatsuki
Enoki, Yuki
Taguchi, Kazuaki
Matsumoto, Kazuaki
Ohge, Hiroki
Suzuki, Hiromichi
Nakamura, Atsushi
Mori, Nobuaki
Morinaga, Yoshitomo
Yamagishi, Yuka
Yoshizawa, Sadako
Yanagihara, Katsunori
Mikamo, Hiroshige
and
Kunishima, Hiroyuki
2022.
Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials.
Journal of Infection and Chemotherapy,
Vol. 28,
Issue. 11,
p.
1536.
Kunishima, Hiroyuki
Ohge, Hiroki
Suzuki, Hiromichi
Nakamura, Atsushi
Matsumoto, Kazuaki
Mikamo, Hiroshige
Mori, Nobuaki
Morinaga, Yoshitomo
Yanagihara, Katsunori
Yamagishi, Yuka
and
Yoshizawa, Sadako
2022.
Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection.
Journal of Infection and Chemotherapy,
Vol. 28,
Issue. 8,
p.
1045.
Giacobbe, Daniele Roberto
Vena, Antonio
Falcone, Marco
Menichetti, Francesco
and
Bassetti, Matteo
2022.
Fidaxomicin for the Treatment of Clostridioides difficile Infection in Adult Patients: An Update on Results from Randomized Controlled Trials.
Antibiotics,
Vol. 11,
Issue. 10,
p.
1365.
Long, Brit
and
Gottlieb, Michael
2022.
Oral fidaxomicin versus vancomycin for Clostridioides difficile infection.
Academic Emergency Medicine,
Vol. 29,
Issue. 12,
p.
1506.
Liao, J. Xin
Appaneal, Haley J.
Vicent, Martie L.
Vyas, Ami
and
LaPlante, Kerry L.
2022.
Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 42,
Issue. 11,
p.
810.
Tashiro, Sho
Taguchi, Kazuaki
Enoki, Yuki
and
Matsumoto, Kazuaki
2023.
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models.
Clinical Microbiology and Infection,
Vol. 29,
Issue. 5,
p.
616.
Thabit, Abrar K.
Aljedaani, Huda J.
Alghamdi, Rawan H.
Badahdah, Raghad M.
Lashkar, Manar O.
and
Alnajjar, Abeer
2023.
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment.
Expert Review of Gastroenterology & Hepatology,
Vol. 17,
Issue. 8,
p.
805.
Alam, Md Zahidul
Markantonis, John E.
and
Fallon, John T.
2023.
Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches.
Tropical Medicine and Infectious Disease,
Vol. 8,
Issue. 12,
p.
506.